These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 27648564

  • 1. Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study.
    Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.
    PLoS Med; 2016 Sep; 13(9):e1002128. PubMed ID: 27648564
    [Abstract] [Full Text] [Related]

  • 2. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, Shaw JE.
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [Abstract] [Full Text] [Related]

  • 3. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
    Shardlow A, McIntyre NJ, Fraser SDS, Roderick P, Raftery J, Fluck RJ, McIntyre CW, Taal MW.
    PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
    [Abstract] [Full Text] [Related]

  • 4. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW.
    BMJ Open; 2017 Aug 23; 7(8):e016528. PubMed ID: 28838895
    [Abstract] [Full Text] [Related]

  • 5. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA, Déruaz-Luyet A, Brodovicz KG, Kimes TM, Rosales AG, Hauske SJ.
    BMC Nephrol; 2020 May 07; 21(1):167. PubMed ID: 32380961
    [Abstract] [Full Text] [Related]

  • 6. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study.
    Major RW, Shepherd D, Medcalf JF, Xu G, Gray LJ, Brunskill NJ.
    PLoS Med; 2019 Nov 07; 16(11):e1002955. PubMed ID: 31693662
    [Abstract] [Full Text] [Related]

  • 7. Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression.
    Neuen BL, Weldegiorgis M, Herrington WG, Ohkuma T, Smith M, Woodward M.
    Am J Kidney Dis; 2021 Sep 07; 78(3):350-360.e1. PubMed ID: 33895181
    [Abstract] [Full Text] [Related]

  • 8. Incidence and Prognosis of Acute Kidney Diseases and Disorders Using an Integrated Approach to Laboratory Measurements in a Universal Health Care System.
    James MT, Levey AS, Tonelli M, Tan Z, Barry R, Pannu N, Ravani P, Klarenbach SW, Manns BJ, Hemmelgarn BR.
    JAMA Netw Open; 2019 Apr 05; 2(4):e191795. PubMed ID: 30951162
    [Abstract] [Full Text] [Related]

  • 9. Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression.
    Ying T, Clayton P, Naresh C, Chadban S.
    BMC Nephrol; 2018 Mar 07; 19(1):55. PubMed ID: 29514605
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study.
    Hirst JA, Hill N, O'Callaghan CA, Lasserson D, McManus RJ, Ogburn E, Mena JMO, Shine B, Taylor CJ, Vazquez-Montes MD, Yang Y, Hobbs FR.
    Br J Gen Pract; 2020 Apr 07; 70(693):e285-e293. PubMed ID: 32041766
    [Abstract] [Full Text] [Related]

  • 11. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A, van der Giet M, Kuhlmann MK, Martus P, Mielke N, Ebert N, Schaeffner ES.
    Am J Kidney Dis; 2021 Mar 07; 77(3):386-396.e1. PubMed ID: 33197533
    [Abstract] [Full Text] [Related]

  • 12. Kidney Function After a Hypertensive Disorder of Pregnancy: A Longitudinal Study.
    Paauw ND, van der Graaf AM, Bozoglan R, van der Ham DP, Navis G, Gansevoort RT, Groen H, Lely AT.
    Am J Kidney Dis; 2018 May 07; 71(5):619-626. PubMed ID: 29289477
    [Abstract] [Full Text] [Related]

  • 13. Chronic Kidney Disease Awareness and Longitudinal Health Outcomes: Results from the REasons for Geographic And Racial Differences in Stroke Study.
    Tummalapalli SL, Vittinghoff E, Crews DC, Cushman M, Gutiérrez OM, Judd SE, Kramer HJ, Peralta CA, Tuot DS, Shlipak MG, Estrella MM.
    Am J Nephrol; 2020 May 07; 51(6):463-472. PubMed ID: 32349001
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E, Kim YS.
    Korean J Intern Med; 2016 Nov 07; 31(6):1120-1130. PubMed ID: 27017386
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: A cohort study.
    Fenton A, Chinnadurai R, Gullapudi L, Kampanis P, Dasgupta I, Ritchie J, Harding S, Ferro CJ, Kalra PA, Taal MW, Cockwell P.
    PLoS Med; 2020 Feb 07; 17(2):e1003050. PubMed ID: 32109242
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H, Li G, Tomlin A, Tilyard MW, Walker R, Schollum J.
    Nephrology (Carlton); 2019 Mar 07; 24(3):308-315. PubMed ID: 29717528
    [Abstract] [Full Text] [Related]

  • 18. Association of Albuminuria and Regression of Chronic Kidney Disease in Adults With Newly Diagnosed Moderate to Severe Chronic Kidney Disease.
    Pasternak M, Liu P, Quinn R, Elliott M, Harrison TG, Hemmelgarn B, Lam N, Ronksley P, Tonelli M, Ravani P.
    JAMA Netw Open; 2022 Aug 01; 5(8):e2225821. PubMed ID: 35943741
    [Abstract] [Full Text] [Related]

  • 19. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, Fluck N, MacLeod A, McNamee P, Prescott G, Smith C.
    Health Technol Assess; 2010 Apr 01; 14(21):1-184. PubMed ID: 20441712
    [Abstract] [Full Text] [Related]

  • 20. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R, Gabbai FB, Chiodini P, Provenzano M, Borrelli S, Garofalo C, Bellizzi V, Russo D, Conte G, De Nicola L, Collaborative Study Group on the Conservative Treatment of CKD of the Italian Society of Nephrology.
    Am J Kidney Dis; 2020 Jan 01; 75(1):30-38. PubMed ID: 31409508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.